234 related articles for article (PubMed ID: 19255287)
1. Diagnostic and prognostic values of pleural fluid procalcitonin in parapneumonic pleural effusions.
Lin MC; Chen YC; Wu JT; Ko YC; Wang CC
Chest; 2009 Jul; 136(1):205-211. PubMed ID: 19255287
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic value of pleural fluid and serum procalcitonin levels in the diagnosis of parapneumonic pleural effusion].
Doğan C; Bilaçeroğlu S; Çirak AK; Özsöz A; Özbek D
Tuberk Toraks; 2013; 61(2):103-9. PubMed ID: 23875587
[TBL] [Abstract][Full Text] [Related]
3. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion.
Lee SH; Lee EJ; Min KH; Hur GY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Lee SY
Clin Biochem; 2013 Oct; 46(15):1484-8. PubMed ID: 23570862
[TBL] [Abstract][Full Text] [Related]
4. Procalcitonin, C-reactive protein, and cell counts in the diagnosis of parapneumonic pleural effusions.
San José ME; Valdés L; Vizcaíno LH; Mora T; Pose A; Soneira E; Crecente C; González-Barcala FJ
J Investig Med; 2010 Dec; 58(8):971-6. PubMed ID: 20930646
[TBL] [Abstract][Full Text] [Related]
5. Serum and pleural fluid procalcitonin in predicting bacterial infection in patients with parapneumonic effusion.
Ko YC; Wu WP; Hsu CS; Dai MP; Ou CC; Kao CH
J Korean Med Sci; 2009 Jun; 24(3):398-402. PubMed ID: 19543500
[TBL] [Abstract][Full Text] [Related]
6. The use of pleural fluid procalcitonin and C-reactive protein in the diagnosis of parapneumonic pleural effusions: a systemic review and meta-analysis.
Zou MX; Zhou RR; Wu WJ; Zhang NJ; Liu WE; Fan XG
Am J Emerg Med; 2012 Nov; 30(9):1907-14. PubMed ID: 22795416
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers of infection for the differential diagnosis of pleural effusions.
Porcel JM; Vives M; Cao G; Bielsa S; Ruiz-González A; Martínez-Iribarren A; Esquerda A
Eur Respir J; 2009 Dec; 34(6):1383-9. PubMed ID: 19541708
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of procalcitonin in pleural effusions.
Wang CY; Hsiao YC; Jerng JS; Ho CC; Lai CC; Yu CJ; Hsueh PR; Yang PC
Eur J Clin Microbiol Infect Dis; 2011 Mar; 30(3):313-8. PubMed ID: 20938702
[TBL] [Abstract][Full Text] [Related]
9. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes.
Krüger S; Ewig S; Marre R; Papassotiriou J; Richter K; von Baum H; Suttorp N; Welte T;
Eur Respir J; 2008 Feb; 31(2):349-55. PubMed ID: 17959641
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and Prognostic Utility of Procalcitonin in Patients Presenting to the Emergency Department with Dyspnea.
Alba GA; Truong QA; Gaggin HK; Gandhi PU; De Berardinis B; Magrini L; Bajwa EK; Di Somma S; Januzzi JL;
Am J Med; 2016 Jan; 129(1):96-104.e7. PubMed ID: 26169892
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of suPAR in differentiating noncardiac pleural effusions from cardiac pleural effusions.
Ozsu S; Oztuna F; Mentese A; Abul Y; Ozlu T
Clin Respir J; 2016 Jan; 10(1):61-6. PubMed ID: 25043397
[TBL] [Abstract][Full Text] [Related]
12. [The application value of the procalcitonin clearance rate on therapeutic effect and prognosis of ventilator associated pneumonia].
Abula A; Wang Y; Ma L; Yu X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Nov; 26(11):780-4. PubMed ID: 25399890
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of C-reactive protein in parapneumonic effusions.
Skouras V; Boultadakis E; Nikoulis D; Polychronopoulos V; Daniil Z; Kalomenidis I; Gourgoulianis KI
Respirology; 2012 Feb; 17(2):308-14. PubMed ID: 21995428
[TBL] [Abstract][Full Text] [Related]
14. Performance of procalcitonin in diagnosing parapneumonic pleural effusions: A clinical study and meta-analysis.
He C; Wang B; Li D; Xu H; Shen Y
Medicine (Baltimore); 2017 Aug; 96(33):e7829. PubMed ID: 28816982
[TBL] [Abstract][Full Text] [Related]
15. Validity of procalcitonin and C-reactive protein measurement when differentiating between benign and malignant pleural effusion.
Botana-Rial M; Casado-Rey P; Leiro-Fernández V; Andrade-Olivié M; Represas-Represas C; Fernández-Villar A
Clin Lab; 2011; 57(5-6):373-8. PubMed ID: 21755828
[TBL] [Abstract][Full Text] [Related]
16. Pleural fluid procalcitonin to distinguish infectious from noninfectious etiologies of pleural effusions.
Khosla R; Khosla SG; Becker KL; Nylen ES
J Hosp Med; 2016 May; 11(5):363-5. PubMed ID: 26821368
[TBL] [Abstract][Full Text] [Related]
17. [The predictor value of peripheral blood procalcitonin levels in the evaluation of prognosis of patients with septic shock].
Chen W; Li LJ; Gu XY; Wang SZ; Zhao L
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Aug; 24(8):470-3. PubMed ID: 22871405
[TBL] [Abstract][Full Text] [Related]
18. The usefulness of pleural fluid presepsin, C-reactive protein, and procalcitonin in distinguishing different causes of pleural effusions.
Watanabe N; Ishii T; Kita N; Kanaji N; Nakamura H; Nanki N; Ueda Y; Tojo Y; Kadowaki N; Bandoh S
BMC Pulm Med; 2018 Nov; 18(1):176. PubMed ID: 30470216
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of a semi-quantitative procalcitonin test and the A-DROP Japanese prognostic scale for predicting mortality among adults hospitalized with community-acquired pneumonia.
Kasamatsu Y; Yamaguchi T; Kawaguchi T; Tanaka N; Oka H; Nakamura T; Yamagami K; Yoshioka K; Imanishi M
Respirology; 2012 Feb; 17(2):330-6. PubMed ID: 22059525
[TBL] [Abstract][Full Text] [Related]
20. Procalcitonin Measurement in Pleural Fluid to Predict Infectious Complications of the Chest Post Lung Resection.
Kouritas V; Zissis C; Bellenis I
J Invest Surg; 2021 Dec; 34(12):1317-1321. PubMed ID: 32806978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
